MH-001

· Vespina Lifesciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MH-001, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers [Phase 1]

See pricing